Page 723 - 16Neonatal Jaundice_compressed

Abbreviations, glossary and references

212. Moslehi MA and Pishva N. Determination of effect of low dose vs moderate dose clofribate on decreasing serum bilirubin in
healthy term neonates. Iranian Journal of Pediatrics 2007; 17:(2)108-12.
213. Mohammadzadeh A, Farhat AS, and Iranpour R. Effect of clofibrate in jaundiced term newborns. Indian Journal of Pediatrics
2005; 72:(2)123-6.
214. Eghbalian F, Pourhossein A, and Zandevakili H. Effect of clofibrate in non-hemolytic indirect hyperbiliru-binemia in full term
neonates. Indian Journal of Pediatrics 2007; 74:(11)1003-6.
215. Zahedpasha Y, hmadpour-Kacho M, Hajiahmadi M et al. Effect of clofibrate in jaundiced full-term infants:a randomized clinical
trial. Archives of Iranian Medicine 2007; 10:(3)349-53.
216. Zahedpasha Y, hmadpour-Kacho M, Hajiahmadi M et al. Efficacy of clofibrate on severe neonatal jaundice associated with
glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). Southeast Asian Journal of Tropical Medicine and
Public Health 2008; 39:(3)557-61.
217. Pascale JA, Mims LC, Greenberg MH et al. Riboflaven and bilirubin response during phototherapy. Pediatric Research 1976;
10:(10)854-6.
218. Pataki L, Matkovics B, Novak Z et al. Riboflavin (vitamin B2) treatment of neonatal pathological jaundice. Acta Paediatrica
Hungarica 1985; 26:(4)341-5.
219. Yurdakok M, Erdem G, and Tekinalp G. Riboflavin in the treatment of neonatal hyperbilirubinemia. Turkish Journal of Pediatrics
1988; 30:(3)159-61.
220. Nicolopoulos D, Hadjigeorgiou E, Malamitsi A et al. Combined treatment of neonatal jaundice with cholestyramine and
phototherapy. Journal of Pediatrics 1978; 93:(4)684-8.
221. Tan KL, Jacob E, Liew DS et al. Cholestyramine and phototherapy for neonatal jaundice. Journal of Pediatrics 1984; 104:(2)284-6.
222. Odell GB, Gutcher GR, Whitington F et al. Enteral administration of agar as an effective adjunct to phototherapy of neonatal
hyperbilirubinemia. Pediatric Research 1983; 17:(10)810-4.
223. Ebbesen F and Moller J. Agar ingestion combined with phototherapy in jaundiced newborn infants. Biology of the Neonate 1977;
31:(1-2)7-9.
224. Martin JR. Phototherapy, phenobarbitone and physiological jaundice in the newborn infant. New Zealand Medical Journal 1974;
79:(517)1022-4.
225. Farhat AS, Mohammadzadeh A, Amir M et al. Effect of cotoneaster tricolor pojark manna on serum bilirubin levels in neonates.
International Journal of Pharmacology 2006; 2:(4)455-8.
226. Yeung CY, Leung CS, and Chen YZ. An old traditional herbal remedy for neonatal jaundice with a newly identified risk. Journal of
Paediatrics and Child Health 1993; 29:(4)292-4.
227. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final
mortality follow-up. Report of the Committee of Principal Investigators. Lancet 1984; 2:(8403)600-4.
228. Salem-Schatz S, Peterson LE, Palmer RH et al. Barriers to first-week follow-up of newborns: findings from parent and clinician
focus groups. Joint Commission Journal on Quality and Safety 2004; 30:(11)593-601.
229. Willis SK, Hannon PR, and Scrimshaw SC. The impact of the maternal experience with a jaundiced newborn on the breastfeeding
relationship. Journal of Family Practice 2002; 51:(5)465.
230. Hannon PR, Willis SK, and Scrimshaw SC. Persistence of maternal concerns surrounding neonatal jaundice: an exploratory study.
Archives of Pediatrics and Adolescent Medicine 2001; 155:(12)1357-63.
231. Davidson L and Thilo EH. How to make kernicterus a never event. NeoReviews 2000; 4:e308-e316.
232. Browk AK and Johnson L. Loss of concern about jaundice and the reemergence of kernicterus in full time infants in the era of
managed care. Yearbook of Neonatal and Perinatal Medicine. Mosby; 1996. p. xvii-xxviii.
233. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatrica, International Journal of
Paediatrics 2000; 89:(10)1213-7.
234. Suresh GK and Clark RE. Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants. Pediatrics
2004; 114:(4)917-24.
235. Bhutani VK and Johnson L. Kernicterus in the 21st century: frequently asked questions. J Perinatol 0 AD; 29:(S1)S20-S24.
236. Newman TB. The power of stories over statistics. British Medical Journal 2003; 327:(7429)1424-7.
237. National Institute for Health and Clinical Excellence. The guidelines manual. London: National Institute for Health and Clinical
Excellence; 2009.
238. Office for National Statistics. Births in England and Wales, selected background data. 2008 [cited 2010 Jan 3]; Available from:
URL:http://www.statistics.gov.uk/statbase/Product.asp?vlnk=14408
239. Personal Social Services Research Unit. Unit Costs of Health and Social Care. Canterbury: University of Kent; 2008.
240. Johnson L, Bhutani VK, Karp K et al. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). Journal of
Perinatology 2009; 29:(S1)S25-S45.
241. Anderson D, Ali K, Blanchette V et al. Guidelines on the use of intravenous immune globulin for hematologic conditions.
Transfusion Medicine Reviews 2007; 21:(2 Suppl 1)S9-56.
242. Department of Health. NHS reference costs 2007-08. London: Department of Health; 2009.
243. Ip S, Chung M, Kulig J et al. An Evidence-Based Review of Important Issues Concerning Neonatal Hyperbilirubinemia. Pediatrics
2004; 114:(1)e130-e153.

517